 | • レポートコード：GIR-107A12665 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、網膜疾患治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。網膜疾患治療の種類別市場規模（黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症）、用途別市場規模（病院薬局、小売薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・網膜疾患治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Novartis、Allergan、Roche、Regeneron、Santen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症 ・用途別分析2016年-2026年：病院薬局、小売薬局、その他 ・網膜疾患治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・網膜疾患治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・網膜疾患治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・網膜疾患治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・網膜疾患治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Retinal Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Retinal Disease Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Retinal Disease Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Retinal Disease Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Market segment by Application, can be divided into
Hospital Pharmacy
Retail Pharmacy
Others
Market segment by players, this report covers
Merck
Novartis
Allergan
Roche
Regeneron
Santen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Retinal Disease Therapeutics
1.2 Classification of Retinal Disease Therapeutics by Type
1.2.1 Overview: Global Retinal Disease Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Retinal Disease Therapeutics Revenue Market Share by Type in 2020
1.2.3 Macular Degeneration
1.2.4 Diabetic Macular Edema
1.2.5 Diabetic Retinopathy
1.2.6 Retinal Vein Occlusion
1.3 Global Retinal Disease Therapeutics Market by Application
1.3.1 Overview: Global Retinal Disease Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Retinal Disease Therapeutics Market Size & Forecast
1.5 Global Retinal Disease Therapeutics Market Size and Forecast by Region
1.5.1 Global Retinal Disease Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Retinal Disease Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Retinal Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Retinal Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Retinal Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Retinal Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Retinal Disease Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Retinal Disease Therapeutics Market Drivers
1.6.2 Retinal Disease Therapeutics Market Restraints
1.6.3 Retinal Disease Therapeutics Trends Analysis
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Retinal Disease Therapeutics Product and Solutions
2.1.4 Merck Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Merck Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Retinal Disease Therapeutics Product and Solutions
2.2.4 Novartis Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan Retinal Disease Therapeutics Product and Solutions
2.3.4 Allergan Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Allergan Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Retinal Disease Therapeutics Product and Solutions
2.4.4 Roche Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 Regeneron
2.5.1 Regeneron Details
2.5.2 Regeneron Major Business
2.5.3 Regeneron Retinal Disease Therapeutics Product and Solutions
2.5.4 Regeneron Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Regeneron Recent Developments and Future Plans
2.6 Santen
2.6.1 Santen Details
2.6.2 Santen Major Business
2.6.3 Santen Retinal Disease Therapeutics Product and Solutions
2.6.4 Santen Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Santen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Retinal Disease Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Retinal Disease Therapeutics Players Market Share
3.2.2 Top 10 Retinal Disease Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Retinal Disease Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Retinal Disease Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Retinal Disease Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Retinal Disease Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Retinal Disease Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Retinal Disease Therapeutics Revenue by Type (2016-2026)
6.2 North America Retinal Disease Therapeutics Revenue by Application (2016-2026)
6.3 North America Retinal Disease Therapeutics Market Size by Country
6.3.1 North America Retinal Disease Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Retinal Disease Therapeutics Revenue by Type (2016-2026)
7.2 Europe Retinal Disease Therapeutics Revenue by Application (2016-2026)
7.3 Europe Retinal Disease Therapeutics Market Size by Country
7.3.1 Europe Retinal Disease Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Retinal Disease Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Retinal Disease Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Region
8.3.1 Asia-Pacific Retinal Disease Therapeutics Revenue by Region (2016-2026)
8.3.2 China Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Retinal Disease Therapeutics Revenue by Type (2016-2026)
9.2 South America Retinal Disease Therapeutics Revenue by Application (2016-2026)
9.3 South America Retinal Disease Therapeutics Market Size by Country
9.3.1 South America Retinal Disease Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Retinal Disease Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Retinal Disease Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Country
10.3.1 Middle East & Africa Retinal Disease Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Retinal Disease Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Retinal Disease Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Retinal Disease Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Retinal Disease Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Retinal Disease Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Retinal Disease Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck Retinal Disease Therapeutics Product and Solutions
Table 9. Merck Retinal Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Retinal Disease Therapeutics Product and Solutions
Table 13. Novartis Retinal Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Allergan Corporate Information, Head Office, and Major Competitors
Table 15. Allergan Major Business
Table 16. Allergan Retinal Disease Therapeutics Product and Solutions
Table 17. Allergan Retinal Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Retinal Disease Therapeutics Product and Solutions
Table 21. Roche Retinal Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Regeneron Corporate Information, Head Office, and Major Competitors
Table 23. Regeneron Major Business
Table 24. Regeneron Retinal Disease Therapeutics Product and Solutions
Table 25. Regeneron Retinal Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Santen Corporate Information, Head Office, and Major Competitors
Table 27. Santen Major Business
Table 28. Santen Retinal Disease Therapeutics Product and Solutions
Table 29. Santen Retinal Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Retinal Disease Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 31. Global Retinal Disease Therapeutics Revenue Share by Players (2019-2021)
Table 32. Breakdown of Retinal Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Retinal Disease Therapeutics Players Head Office, Products and Services Provided
Table 34. Retinal Disease Therapeutics Mergers & Acquisitions in the Past Five Years
Table 35. Retinal Disease Therapeutics New Entrants and Expansion Plans
Table 36. Global Retinal Disease Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 37. Global Retinal Disease Therapeutics Revenue Share by Type (2016-2021)
Table 38. Global Retinal Disease Therapeutics Revenue Forecast by Type (2021-2026)
Table 39. Global Retinal Disease Therapeutics Revenue by Application (2016-2021)
Table 40. Global Retinal Disease Therapeutics Revenue Forecast by Application (2021-2026)
Table 41. North America Retinal Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Retinal Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Retinal Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Retinal Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Retinal Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Retinal Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Retinal Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Retinal Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Retinal Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Retinal Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Retinal Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Retinal Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Retinal Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Retinal Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Retinal Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Retinal Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Retinal Disease Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Retinal Disease Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Retinal Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Retinal Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Retinal Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Retinal Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Retinal Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Retinal Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Retinal Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Retinal Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Retinal Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Retinal Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Retinal Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Retinal Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Retinal Disease Therapeutics Picture
Figure 2. Global Retinal Disease Therapeutics Revenue Market Share by Type in 2020
Figure 3. Macular Degeneration
Figure 4. Diabetic Macular Edema
Figure 5. Diabetic Retinopathy
Figure 6. Retinal Vein Occlusion
Figure 7. Retinal Disease Therapeutics Revenue Market Share by Application in 2020
Figure 8. Hospital Pharmacy Picture
Figure 9. Retail Pharmacy Picture
Figure 10. Others Picture
Figure 11. Global Retinal Disease Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Retinal Disease Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Retinal Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 14. Global Retinal Disease Therapeutics Revenue Market Share by Region in 2020
Figure 15. North America Retinal Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Retinal Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Retinal Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Retinal Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Retinal Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Retinal Disease Therapeutics Market Drivers
Figure 21. Retinal Disease Therapeutics Market Restraints
Figure 22. Retinal Disease Therapeutics Market Trends
Figure 23. Merck Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. Allergan Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. Regeneron Recent Developments and Future Plans
Figure 28. Santen Recent Developments and Future Plans
Figure 29. Global Retinal Disease Therapeutics Revenue Share by Players in 2020
Figure 30. Retinal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Retinal Disease Therapeutics Revenue Market Share in 2020
Figure 32. Global Top 10 Players Retinal Disease Therapeutics Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Retinal Disease Therapeutics Revenue Share by Type in 2020
Figure 35. Global Retinal Disease Therapeutics Market Share Forecast by Type (2021-2026)
Figure 36. Global Retinal Disease Therapeutics Revenue Share by Application in 2020
Figure 37. Global Retinal Disease Therapeutics Market Share Forecast by Application (2021-2026)
Figure 38. North America Retinal Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 39. North America Retinal Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 40. North America Retinal Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 41. United States Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Retinal Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 45. Europe Retinal Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 46. Europe Retinal Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 47. Germany Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Retinal Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Retinal Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Retinal Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 55. China Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Retinal Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 62. South America Retinal Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 63. South America Retinal Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Retinal Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Retinal Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Retinal Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Retinal Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界の網膜生物製剤市場予測（～2024年）：企業別、地域別、種類・用途別 Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat r…- 世界の網膜医薬品市場予測（～2024年） Retinal Pharmaceuticals is primarily used to treat retinal-related diseases. Retina is a layer of nerve tissue lining the back of the eye. Retina receives light and convert it into neural signals, and send these signals to the brain for visual recognition. The central part of the retina is known as …
- 世界の性感染症治療市場 2021：企業別、地域別、種類・用途別 The Sexually Transmitted Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界のカナバン病治療薬市場 2021：企業別、地域別、種類・用途別 The Canavan Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- カナバン病治療薬市場：世界及び中国市場分析・予測（～2024年） Canavan Disease Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Canavan Disease Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Canavan Dise…